Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00456-3/abstract?utm_campaign=infocusalerts-neurology&utm_medium=email&dgcid=hubspot_email_infocusalerts-neurology_feature&_hsenc=p2ANqtz-8xRo3Q064ozz7k5KV0zXuBNZ2Pq9zkcjJwNxVvAYoyPKpeHr3yF1ByDXgS7QSN-LkW1rblCKcAxdp5lDc8sXo0bTLiQw&_hsmi=348386757&utm_content=347785879&utm_source=hs_email